High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial

BACKGROUND: Imatinib is the standard of care for newly diagnosed chronic-phase chronic myeloid leukemia. The largest randomized clinical trial of imatinib was the multinational IRIS trial in which 1106 patients were randomized to receive either imatinib 400 mg/day or a standard regimen of interferon...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Guilhot, François, Druker, Brian, Larson, Richard A., Gathmann, Insa, So, Charlene, Waltzman, Roger, O’Brien, Stephen G.
Formáid: Artigo
Teanga:Inglês
Foilsithe: Ferrata Storti Foundation 2009
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2791923/
https://ncbi.nlm.nih.gov/pubmed/19648168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.010629
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla